Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo
Open Access
- 1 April 1999
- Vol. 10 (4) , 431-438
- https://doi.org/10.1016/s1074-7613(00)80043-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive InfectionThe Journal of Infectious Diseases, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmissionEuropean Journal of Immunology, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal AntibodyScience, 1994
- Rapid Loss of CD4 + T Cells in Human-PBL-SCID Mice by Noncytopathic HIV IsolatesScience, 1993
- hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120AIDS, 1993
- Human Immunodeficiency Virus Infection of Human-PBL-SCID MiceScience, 1991
- Neutralization of Multiple HIV-1 Isolates from a Single Subject by Autologous Sequential SeraThe Journal of Infectious Diseases, 1990
- Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous seraAIDS, 1990